Advanced Viral Research Corp (786623) SEC Filing 10-Q Quarterly report for the period ending Saturday, June 30, 2007

Advanced Viral Research Corp

CIK: 786623

View differences made from one quarter to another to evaluate Advanced Viral Research Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Advanced Viral Research Corp.


Assess how Advanced Viral Research Corp's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Advanced Viral Research Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2007 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
CIK: 786623
Form Type: 10-Q Quarterly Report
Accession Number: 0000950144-07-007832
Submitted to the SEC: Tue Aug 14 2007 1:02:16 PM EST
Accepted by the SEC: Tue Aug 14 2007
Period: Saturday, June 30, 2007
Industry: Pharmaceutical Preparations

External Resources:

Bookmark the Permalink: